BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17229006)

  • 1. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders.
    Lucas GJ; Daroszewska A; Ralston SH
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P31-7. PubMed ID: 17229006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders.
    Ralston SH
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):101-11. PubMed ID: 18328984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
    Daroszewska A; Ralston SH
    Nat Clin Pract Rheumatol; 2006 May; 2(5):270-7. PubMed ID: 16932700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
    Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH
    J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Paget's disease of bone.
    Daroszewska A; Ralston SH
    Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.
    Lucas GJ; Mehta SG; Hocking LJ; Stewart TL; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Watts GD; Ralston SH; Kimonis VE
    Bone; 2006 Feb; 38(2):280-5. PubMed ID: 16199218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
    Whyte MP
    Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent.
    Lucas GJ; Riches PL; Hocking LJ; Cundy T; Nicholson GC; Walsh JP; Ralston SH
    J Bone Miner Res; 2008 Jan; 23(1):58-63. PubMed ID: 17907922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SQSTM1 and Paget's disease of bone.
    Layfield R; Hocking LJ
    Calcif Tissue Int; 2004 Nov; 75(5):347-57. PubMed ID: 15365659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Inherited forms of Paget's Disease and Related Syndromes.
    Ralston SH; Taylor JP
    Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein gene mutations: clinical and neuropathologic features.
    Guyant-Maréchal L; Laquerrière A; Duyckaerts C; Dumanchin C; Bou J; Dugny F; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2006 Aug; 67(4):644-51. PubMed ID: 16790606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
    Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH
    J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
    Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
    J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and aetiology of Pagetic disorders of bone.
    Helfrich MH; Hocking LJ
    Arch Biochem Biophys; 2008 May; 473(2):172-82. PubMed ID: 18359282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
    Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
    J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
    Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
    Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
    Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
    J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.
    Sparks AB; Peterson SN; Bell C; Loftus BJ; Hocking L; Cahill DP; Frassica FJ; Streeten EA; Levine MA; Fraser CM; Adams MD; Broder S; Venter JC; Kinzler KW; Vogelstein B; Ralston SH
    Calcif Tissue Int; 2001 Mar; 68(3):151-5. PubMed ID: 11351498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.
    Guinto JB; Ritson GP; Taylor JP; Forman MS
    Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.